The University of Chicago Header Logo

Connection

Kenneth Gordon to Phosphodiesterase 4 Inhibitors

Back to Details
This is a "connection" page, showing publications Kenneth Gordon has written about Phosphodiesterase 4 Inhibitors.
Kenneth Gordon
Connection Strength
0.135
Phosphodiesterase 4 Inhibitors
  1. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1). J Am Acad Dermatol. 2015 Jul; 73(1):37-49.
    View in: PubMed
    Score: 0.135
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.